The 9th Treg-Directed Therapies Summit explores advancements in Treg-directed therapies, focusing on engineered Treg cells, immune tolerance, and clinical implementation for autoimmune treatment.
Key Topics
Treg Cell Biology to Supercharge Development of Treg Directed Therapies
The Potential of Engineered Treg Cells For the Modulation of Antigen Specific Responses
Maximizing Immune Tolerance through Generation of Antigen Specific Tregs
How Treg Directed Therapies Are Being Successfully Implemented in the Clinic
Ensuring Maintenance of Treg Cells for Enhanced Therapeutic Effect
Treg Adoptive Cell Therapies Using Novel Expansion Techniques